In a highly anticipated conversation with BioPharma BoardRoom, Eric Hsu, Director of Key Account Management at Samsung Biologics, shares groundbreaking ins...
Largely driven by increasing incidence of chronic and infectious diseases and growth in biotechnology and pharma industries, the global immunoassay market ...
There is growing recognition that the experimental model systems used in many cancer research projects, which include 2D cell cultures, patient-derived xen...
Organoids also hold advantages over animal models, which inherently possess species-dependent differences and can be logistically and ethically challenging...
Clinical trials recruited hundreds of thousands of patients, while families in lockdown waited, hoping for regulatory approval of a COVID-19 vaccine that w...
Artificial Intelligence in Healthcare In healthcare, AI has the potential to drive scientific breakthroughs, aid in diagnosis, treatment, and management o...
© 2026 Biopharma Boardroom. All Rights Reserved.
